Primary |
Product Used For Unknown Indication |
51.2% |
Pain |
23.9% |
Drug Abuse |
6.0% |
Back Pain |
5.0% |
Breakthrough Pain |
4.2% |
Substance Abuse |
1.2% |
Analgesic Therapy |
0.9% |
Arthralgia |
0.9% |
Neck Pain |
0.7% |
Cancer Pain |
0.7% |
Neuralgia |
0.7% |
Fibromyalgia |
0.6% |
Intervertebral Disc Degeneration |
0.6% |
Drug Dependence |
0.6% |
Arthritis |
0.5% |
Intervertebral Disc Protrusion |
0.5% |
Neuropathy Peripheral |
0.4% |
Pain In Extremity |
0.4% |
Rheumatoid Arthritis |
0.4% |
Anxiety |
0.4% |
|
Drug Ineffective |
9.2% |
Drug Effect Decreased |
8.7% |
Vomiting |
8.4% |
Drug Dependence |
8.2% |
Pain |
8.0% |
Inadequate Analgesia |
7.7% |
Nausea |
7.7% |
Drug Abuse |
5.8% |
Medication Residue Present |
5.1% |
Substance Abuse |
4.0% |
Wrong Technique In Drug Usage Process |
3.9% |
Somnolence |
3.6% |
Overdose |
3.4% |
Unevaluable Event |
3.1% |
Therapeutic Response Delayed |
3.0% |
Drug Withdrawal Syndrome |
2.4% |
Malaise |
2.0% |
Feeling Abnormal |
2.0% |
Pruritus |
2.0% |
Intentional Drug Misuse |
1.9% |
|
Secondary |
Product Used For Unknown Indication |
36.9% |
Pain |
20.6% |
Back Pain |
9.0% |
Breakthrough Pain |
5.6% |
Arthralgia |
3.6% |
Neck Pain |
3.2% |
Arthritis |
2.6% |
Intervertebral Disc Protrusion |
2.4% |
Intervertebral Disc Degeneration |
2.4% |
Fibromyalgia |
1.9% |
Drug Abuse |
1.7% |
Pain In Extremity |
1.5% |
Neuropathy Peripheral |
1.3% |
Osteoarthritis |
1.2% |
Anxiety |
1.2% |
Cancer Pain |
1.2% |
Musculoskeletal Pain |
1.0% |
Neuralgia |
1.0% |
Rheumatoid Arthritis |
0.9% |
Depression |
0.8% |
|
Vomiting |
15.7% |
Pain |
13.9% |
Inadequate Analgesia |
7.3% |
Drug Effect Decreased |
7.1% |
Unevaluable Event |
6.2% |
Drug Ineffective |
5.9% |
Nausea |
5.9% |
Therapeutic Response Delayed |
5.9% |
Medication Residue Present |
5.7% |
Somnolence |
5.1% |
Weight Decreased |
3.5% |
Wrong Technique In Drug Usage Process |
2.9% |
Drug Dependence |
2.4% |
Pruritus |
2.2% |
Suicidal Ideation |
2.2% |
Drug Abuse |
1.8% |
Pneumonia |
1.6% |
Road Traffic Accident |
1.6% |
Tremor |
1.6% |
Headache |
1.5% |
|
Concomitant |
Product Used For Unknown Indication |
43.5% |
Pain |
19.6% |
Breakthrough Pain |
15.2% |
Spinal Column Stenosis |
8.7% |
Scoliosis |
4.3% |
Back Pain |
2.2% |
Cancer Pain |
2.2% |
Intervertebral Disc Degeneration |
2.2% |
Spinal Osteoarthritis |
2.2% |
|
Drug Ineffective |
42.1% |
Tremor |
21.1% |
Application Site Rash |
5.3% |
Drug Effect Decreased |
5.3% |
Drug Withdrawal Syndrome |
5.3% |
Feeling Abnormal |
5.3% |
Local Swelling |
5.3% |
Respiratory Depression |
5.3% |
Strabismus |
5.3% |
|
Interacting |
Product Used For Unknown Indication |
50.0% |
Complex Regional Pain Syndrome |
15.4% |
Deep Vein Thrombosis |
7.7% |
Muscle Disorder |
7.7% |
Nervous System Disorder |
7.7% |
Heart Transplant |
3.8% |
Procedural Pain |
3.8% |
Pulmonary Hypertension |
3.8% |
|
Hyperhidrosis |
50.0% |
Myoclonus |
25.0% |
Unevaluable Event |
25.0% |
|